Ticker Symbol: BGNE

BeiGene Ltd - ADR

$389.34 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: China (Mainland) Currency: USD Asset Type: ADR CIK:0001651308

Company Profile

BeiGene is a biotechnology company that specializes in the development of drugs for cancer treatment. BeiGene has developed several pharmaceuticals, including tislelizumab, a checkpoint inhibitor, and zanubrutinib.

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Standard Industrial Classification Code (SIC code): 2834

Address: No. 30 Science Park Road

Website: http://www.beigene.com/

CEO: John Oyler

Tags:

Health Technology
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 20, 2023 03:00 PM EST

Previous Close: $165.21

Change: $6.54 ( 4.12%)

Days Range: $156.56 - $165.75

Beta: 0.80

52wk. High: $280.62

52wk. Low: $142.02

Ytd. Change -20.76%

50 Day Moving Average: $187.16

200 Day Moving Average: $209.82

Shares Outstanding: 97005674

Valuation

Market Cap: 1.6T

PE Ratio: -9.95

EPS (TTM): -16.61

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A